<html>
 <head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
 </head>
 <body>
  <p>
  </p>
  <p style="text-align: center; background: white; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Calibri', serif;" align="center">
   <a name="_top" href="">
   </a>
   <img src="https://meltwater-apps-production.s3.amazonaws.com/uploads/images/57ffea234e5a197ebe5e8593/blobid12_1485798467729.png" width="770" height="96"/>
  </p>
  <p style="text-align: center; background: white; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Calibri', serif;" align="center">
  </p>
  <div style="background: white; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Calibri', serif;">
   <hr align="left" size="3" width="100%"/>
  </div>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-size: 16.0pt; font-family: 'Calibri',sans-serif; color: black;">
   </span>
  </p>
  <div style="margin: 0in 0in 0.0001pt; line-height: normal; background: white; font-size: 11pt; font-family: Calibri, sans-serif;">
   <hr align="left" size="3" width="100%"/>
  </div>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 16.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 16.0pt; color: black;">
    In the
    <strong>
     February 16th
    </strong>
    release:
   </span>
  </p>
  <ul style="margin-bottom: 0in;" type="disc">
   <li style="color: black; line-height: normal; margin: 0in 0in 8pt; font-size: 11pt; font-family: Calibri, sans-serif;">
    <span style="font-size: 16.0pt;">
     <a style="color: blue; text-decoration: underline;" href="#west_nile">
      A Single Mutation May Impact Infectivity of West Nile and Similar Viruses
     </a>
     (
     <em>
      image
     </em>
     )
    </span>
   </li>
   <li style="color: black; line-height: normal; margin: 0in 0in 8pt; font-size: 11pt; font-family: Calibri, sans-serif;">
    <span style="font-size: 16.0pt;">
     <a style="color: blue; text-decoration: underline;" href="#chikungunya">
      Mouse study reveals potential drug target for arthritis caused by chikungunya virus
     </a>
     (
     <em>
      image
     </em>
     )
    </span>
   </li>
  </ul>
  <p style="margin: 0in 0in 0.0001pt 0.5in; text-align: center; line-height: normal; background: white; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <strong>
    <span style="font-size: 16.0pt; color: black;">
     EMBARGO: February 16, 2017 11 AM Pacific / 2 PM Eastern Time
    </span>
   </strong>
  </p>
  <div style="margin: 0in 0in 0.0001pt; line-height: normal; background: white; vertical-align: baseline; font-size: 11pt; font-family: Calibri, sans-serif;">
   <hr align="left" size="2" width="100%"/>
  </div>
  <p style="margin: 0in 0in 0.0001pt; text-align: center; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <strong>
    <span style="font-size: 12.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in 8pt; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <a name="west_nile" href="">
   </a>
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     A Single Mutation May Impact Infectivity of West Nile and Similar Viruses
    </span>
   </strong>
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     <br/>
    </span>
   </strong>
   <em>
    <span style="font-size: 14.0pt; color: black;">
     Mutation in viral envelope protein may expose relatively hidden protein region to antibodies
    </span>
   </em>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <img src="https://meltwater-apps-production.s3.amazonaws.com/uploads/images/57ffea234e5a197ebe5e8593/blobid4_1486677368868.jpg" width="415" height="230" align="left" hspace="12"/>
   <span style="font-size: 14.0pt; color: black;">
    A mutation that impacts changes
 in the shape of an essential viral protein may influence the infectivity of West Nile and other viruses in the flavivirus family, according to a new study in
    <em>
     PLOS Pathogens.
    </em>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
    Flaviviruses are responsible for many diseases of global health importance, including West Nile, dengue, and Zika fevers. However, many of these diseases have no effective vaccines or treatments. Some researchers,
 including Leslie Goo of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Maryland, hope that a better understanding of how flaviviruses interact with the immune system’s antibodies could enable better prevention
 and treatment.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
    In the new study, Goo led a research team in carrying out a series of experiments to test the effects of different mutations in a flavivirus protein called envelope (E) protein, which plays a major role in infection.
 Using E protein from West Nile, they identified a mutation called T198F that makes E protein more sensitive to inhibition with antibodies.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
    E protein is known to change shape in a process known as “viral breathing,” which alternately hides and exposes certain parts of the protein. Further experiments revealed that T198F occurs in a part of E protein
 that regulates viral breathing, resulting in exposure of another, otherwise poorly accessible part of the protein.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
    The scientists introduced the T198F mutation into different flaviviruses and found that, in West Nile and dengue, but not in Zika, it did indeed increase accessibility of a relatively hidden protein region, making
 this region more vulnerable to antibodies. When introduced into mice, West Nile virus containing this mutation reduced infectivity and disease severity.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
    Further research is needed to better understand E protein viral breathing behavior, as well as how it impacts flavivirus infection in mice and, possibly, humans. The resulting knowledge could help pave the way
 to new vaccines and antiviral drugs.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     In your coverage please use this URL to provide access to the freely available article in
     <em>
      PLOS Pathogens
     </em>
     :
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fdx.doi.org%2F10.1371%2Fjournal.ppat.1006178&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=xXcCXhCjE6lVa2ny4TXmPFlNVOy_pjhiXlJWbPuW6ik">
     http://dx.doi.org/10.1371/journal.ppat.1006178
    </a>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Press-only preview:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fplos.io%2F2lwkRLb&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=LmLRR2wkYirtMRzA-HBHjWdk_LAqk9NrOl39MF_l0Nc">
     http://plos.io/2lwkRLb
    </a>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Contact:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    National Institutes of Health (NIH),
    <a style="color: blue; text-decoration: underline;" href="mailto:niaidnews@niaid.nih.gov">
     niaidnews@niaid.nih.gov
    </a>
    , ph: +1 301-402-1663
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Citation:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    Goo L, VanBlargan LA, Dowd KA, Diamond MS, Pierson TC (2017) A single mutation in the envelope protein modulates flavivirus antigenicity,
 stability, and pathogenesis. PLoS Pathog 13(2): e1006178. doi:10.1371/journal.ppat.1006178
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Image Credit:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    A. Wilson; Brian W.J. Mahy, BSc, MA, PhD, ScD, DSc, USCDCP
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Funding:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    This work was supported by grants from the Burroughs Wellcome Fund (MSD) and the National Institutes of Health (R01 AI073755) (MSD),
 and by the National Institute of Allergy and Infectious Diseases Division of Intramural Research (TCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Competing Interests:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    The authors have declared that no competing interests exist.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
    <a style="color: blue; text-decoration: underline;" href="#_top">
     Back to the Top
    </a>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <div style="margin: 0in 0in 0.0001pt; line-height: normal; background: white; vertical-align: baseline; font-size: 11pt; font-family: Calibri, sans-serif;">
   <hr align="left" size="2" width="100%"/>
  </div>
  <p style="margin: 0in 0in 0.0001pt; text-align: center; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <strong>
    <span style="font-size: 12.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; text-align: center; line-height: normal; vertical-align: baseline; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <a name="chikungunya" href="">
   </a>
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Mouse study reveals potential drug target for arthritis caused by chikungunya virus
    </span>
   </strong>
  </p>
  <p style="text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in 8pt; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <em>
    <span style="font-size: 14.0pt; color: black;">
     A specific immune system proteinase may promote arthritic inflammation after viral infection
    </span>
   </em>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <img src="https://meltwater-apps-production.s3.amazonaws.com/uploads/images/57ffea234e5a197ebe5e8593/blobid5_1486677368927.jpg" width="408" height="236" align="left" hspace="12"/>
   <span style="font-size: 14.0pt;">
    An immune system proteinase called granzyme A
 appears to promote arthritic inflammation in mice infected with chikungunya virus, scientists report in a new
    <em>
     PLOS Pathogens
    </em>
    study. The study also suggested that granzyme A could serve as a potential target for new drugs to treat chikungunya and related viral arthritides in people.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    Chikungunya virus is transmitted by mosquitoes, with a recent epidemic causing millions of cases globally. While it is rarely fatal, chikungunya can cause severe, chronic polyarthritis (inflammation in multiple joints) and/or
 polyarthralgia (pain in multiple joints). Current standard anti-inflammatory drug treatment can relieve these symptoms, but they are often not particularly effective.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    To aid research into potential new treatments, Jane Wilson and Natalie Prow of QIMR Berghofer Medical Research Institute, Australia, and colleagues exploited an adult wild-type mouse model of chikungunya virus infection and
 diseases previously developed by the group. In the new study, they use RNA-Seq technology to examine in detail the mouse inflammatory responses to infection. They found that genes activated in the mouse model closely mirrored genes known to be activated in
 infected humans, providing a level of validation of the model.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    Particularly prominent in the RNA-Seq analysis was the up-regulation of a number of granzymes, a group of proteinases secreted by immune cells that were originally thought to be involved in killing (via apoptosis) virus infected
 cells or other target cells.  However, an emerging consensus supported by the new
    <em>
     PLOS Pathogens
    </em>
    study, is that some granzymes (particularly granzyme A and K) have a role in promoting inflammation.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    Exploring further, the scientists showed that mice missing the granzyme A gene, when infected with chikungunya virus, experienced dramatically less foot swelling and arthritis.  Furthermore, treating mice with a granzyme A inhibitor
 also significantly reduced foot swelling and arthritis.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    They also found elevated granzyme A levels in blood samples taken from non-human primates infected with chikungunya, as well as from human chikungunya patients. Overall the findings suggest that granzyme A could serve as a potential
 drug target for anti-inflammatory treatments for chikungunya—and perhaps also for other inflammatory diseases. Further research will be needed to explore this potential and determine how well the new findings can be extended from mice to humans.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     In your coverage please use this URL to provide access to the freely available article in
     <em>
      PLOS Pathogens
     </em>
     :
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fdx.doi.org%2F10.1371%2Fjournal.ppat.1006155&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=A02Ijmcp4PMUuq9zcchayOTt5V-X_-pA2q0tkMi68Pk">
     http://dx.doi.org/10.1371/journal.ppat.1006155
    </a>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Press-only preview:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fplos.io%2F2kxCUlJ&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=c9gf3jTDh09-lVUUMZtDx91tszOb-SRGI7xY8pk-Fzw">
     http://plos.io/2kxCUlJ
    </a>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Contact:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    Andreas Suhrbier,
    <a style="color: blue; text-decoration: underline;" href="mailto:Andreas.Suhrbier@qimrberghofer.edu.au">
     Andreas.Suhrbier@qimrberghofer.edu.au
    </a>
    , ph: +61 7 3362 0415 (diverts to mobile 24/7)
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Citation:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    Wilson JAC, Prow NA, Schroder WA, Ellis JJ, Cumming HE, Gearing LJ, et al. (2017) RNA-Seq analysis of chikungunya virus infection
 and identification of granzyme A as a major promoter of arthritic inflammation. PLoS Pathog 13(2): e1006155. doi:10.1371/journal.ppat.1006155
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Image Credit:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    Wilson et al. (2017)
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Funding:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    The work was primarily funded by the National Health and Medical Research Council (NHMRC), Australia (grant APP613622) (
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fwww.nhmrc.gov.au%2F&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=31wi3kvXh8ismRfmBcT4jbdTeT3hAVdRADSCGUubtxk">
     www.nhmrc.gov.au
    </a>
    ).
 JACW was awarded an Australian Postgraduate Award scholarship by the School of Medicine, University of Queensland. NAP was in part supported by an Advance Queensland Research Fellowship from the Queensland government. AS is a principal research fellow with
 the NHMRC. BSL3 equipment was funded by the Queensland Tropical Health Alliance (
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fwww.qtha.org.au%2F&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=hM5_uq4KdNAIVWQrv03Tk9tMLKedUiPcfHpSAg14UDo">
     www.qtha.org.au
    </a>
    ).
 The NHP studies were funded by (i) “Programme d’Investissements d’Avenir” (PIA) under Grant ANR-11-INBS-0008 funding the Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure and (ii) the Integrated Chikungunya
 Research (ICRES) project of the European Union FP7 project grant agreement no. 261202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: black;">
     Competing Interests:
    </span>
   </strong>
   <span style="font-size: 14.0pt; color: black;">
    The authors have declared that no competing interests exist.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
    <a style="color: blue; text-decoration: underline;" href="#_top">
     Back to the Top
    </a>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="color: red;">
   </span>
  </p>
  <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <hr align="left" size="2" width="100%"/>
  </div>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 10.0pt; color: black;">
    <br/>
   </span>
   <strong>
    <span style="font-size: 12.0pt; color: black;">
     About
     <em>
      PLOS Pathogens
     </em>
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <em>
    <span style="font-size: 12.0pt; color: #211f20; background: white;">
     PLOS
    </span>
   </em>
   <span style="font-size: 12.0pt; color: #211f20; background: white;">
    Pathogens is the first Open Access journal for breakthroughs in understanding pathogens and their interactions
 with host organisms. The journal publishes original research and commentary that yield novel insights into pathogenesis that are of broad interest and importance to researchers studying pathogens and pathogen-host interactions.  For
   </span>
   <span style="font-size: 12.0pt; color: black;">
    more
 information, visit
   </span>
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fjournals.plos.org%2Fplospathogens&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=IDc8dUNyWfmbofAfuN1dHrw6_CCHlMC4zJJ50hU5gzg">
     <span style="font-family: 'Calibri',sans-serif;">
      http://journals.plos.org/plospathogens
     </span>
    </a>
   </span>
   <span style="font-size: 12.0pt; color: black;">
    ,
 and follow @PLOSPathogens on Twitter.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 12.0pt; color: black;">
     Media and Copyright Information
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; color: black;">
    For information about
    <em>
     PLOS Pathogens
    </em>
    relevant to journalists, bloggers and press officers, including details of our press release process and embargo policy, visit
   </span>
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=http%3A%2F%2Fjournals.plos.org%2Fplospathogens%2Fs%2Fpress-and-media&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=fD9g9je4sjJgRHiAIFwYdpYXuBiwzVNosFlmPUtstF4">
     <span style="font-family: 'Calibri',sans-serif;">
      http://journals.plos.org/plospathogens/s/press-and-media
     </span>
    </a>
   </span>
   <span style="font-size: 12.0pt; color: black;">
    .
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; color: black;">
    PLOS journals publish under a
   </span>
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=https%3A%2F%2Fcreativecommons.org%2Flicenses%2Fby%2F4.0%2F&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=Dt1dMGFcluZr2Nqb9PkBZ1sQG3tFWQONQddb4Cl8KEY">
     <span style="font-family: 'Calibri',sans-serif;">
      Creative
 Commons Attribution License
     </span>
    </a>
   </span>
   <span style="font-size: 12.0pt; color: black;">
    , which permits free reuse of all materials published with the article, so long as the work is cited.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 12.0pt; color: black;">
     About the Public Library of Science
    </span>
   </strong>
   <span style="font-size: 12.0pt; color: black;">
    <br/>
    Public Library of Science (PLOS) is a nonprofit Open Access (OA) publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by leading a transformation in research communication. The PLOS suite of journals contain
 rigorously peer-reviewed Open Access research articles from all areas of science and medicine, together with expert commentary and analysis. In addition to journals, the organization advances innovations in scientific publishing through Collections, Communities
 and The PLOS Blog Network. Founded to catalyze a revolution in scientific publishing by demonstrating the value and feasibility of Open Access publication, PLOS is committed to innovative and forward-looking solutions to scientific communication. For more
 information, visit
   </span>
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
    <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=https%3A%2F%2Fwww.plos.org%2Fwho-we-are&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=BqOSi3ppOyv3Csnw0_v_icvsFn3i04AZXukktmEDzM4">
     <span style="font-family: 'Calibri',sans-serif;">
      https://www.plos.org/who-we-are
     </span>
    </a>
    .
   </span>
   <span style="font-size: 12.0pt; color: black;">
    <br/>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 12.0pt; color: black;">
     Disclaimer
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; color: black;">
    This press release refers to upcoming articles in
    <em>
     PLOS Pathogens
    </em>
    . The releases have been provided by the article authors and/or journal staff. Any opinions expressed are the personal views of the contributors,
 and do not necessarily represent the views or policies of PLOS. PLOS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; color: black;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: black;">
    <a style="color: blue; text-decoration: underline;" href="#_top">
     Back to the Top
    </a>
   </span>
  </p>
  <br/>
  <br/>
  <p style="text-align:center; clear:both;">
   <span class="sl-translate">
    This email was sent to newsdesk@sciencemediacenter.de
   </span>
   <br/>
   <span>
    PLOS, 1160 Battery Street, Suite 100, San Francisco, California 94111, United States
   </span>
   <br/>
   <a class="sl-translate" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D&G=0&R=https%3A%2F%2Finfluencers.meltwater.com%2Funsubscribe%2FICM%3Fc%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%26iv%3D6880757267181251b2e25aa8b33d2f7e&I=20170209225556.000003bbea01%40mail6-51-ussnn1&X=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D&S=8VYQ1SNREkM5tO3uOG064lN4Q4jYqwy4XIo_AwG_oFg">
    Unsubscribe
   </a>
  </p>
  <img src="http://trk.email.dynect.net/trk.php?a=/o2/0/w8Bl7ZSLqC%2BFFEF9P0XN9HJB14ltnTgt2r4zKtmGsiA5bfE55aykH1lwa3f%2Fsypw1FEvmfoWmWdK%2F53CoGH%2FVZiE0N0RN9WpU8pK0Llv%2FeghEVkig%2B4yFSYMjyTmfdcQyoQOJ0WNIkI%3D/i.gif&i=20170209225556.000003bbea01%40mail6-51-ussnn1&x=MHwxMDQ2NzU4OjU4OWNlNjIyZTM5OGI3Y2I1MGRkMDhhNTs%3D" alt="" width="2" height="2"/>
 </body>
</html>
